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Abstract 
Polymeric biomaterials are used as substitutes for damaged tissue and for the stimulation of 
tissue regeneration. One class of polymeric biomaterials are bioresorbable polymers that 
degrade both in vitro and in vivo and are used as a temporary support for tissue 
regeneration. Among the various types of bioresorbable polymers, -hydroxy acids 
including the different forms of poly(lactic acid) (PLA), such as poly(L-lactic acid), poly(D-
lactic acid) and poly(DL-lactic acid), as well as poly(glycolic acid) and polycaprolactone, 
have been extensively studied. These polymers are well known for their good 
biocompatibility, with their degradation products being eliminated from the body by 
metabolic pathways. Many reports have shown that the different PLA-based substrates do 
not present toxicity since the cells were found to differentiate over the different polymers, as 
demonstrated by the production of extracellular matrix components by various cell types. In 
this chapter, we describe the use of -hydroxy acids, highlighting the different forms of PLA 
scaffolds used as cell culture substrates and their applications in clinical practice. The 
chapter is divided into (1) Introduction; (2) Bioresorbable devices as cell culture substrates; 
(3) Cell adhesion to polymer substrates; (4) Tissue engineering and bioresorbable polymers; 
(5) Cell growth and proliferation on bioresorbable polymers; (6) Bioresorbable polymers for 
cartilage engineering; (7) Bioresorbable polymers for bone tissue engineering; (8) 
Bioresorbable polymers for skin tissue engineering, and (9) Conclusion. 
 
1. Introduction 
For centuries, extensive tissue injuries normally originating from mechanical trauma or 
degenerative diseases have been a challenge because of the scarcity of therapeutic resources. 
Removal of the damaged part was the most common practice, which resulted in a series of 
limitations of the affected patient and in a significant decrease in quality of life. Thus, 
replacement and/or regeneration of the damaged body regions became the new target. The 
increase in life expectancy resulting from the discovery of antibiotics and chemotherapy, as 
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well as from improved sanitary and hygiene conditions, has encouraged the search for 
methods to replace damaged tissues [1]. 
There are two procedures used for the treatment of the failure or loss of tissues and organs: 
transplants and implants. In the case of transplants, tissues or organs are obtained from 
living donors (e.g., heart or kidneys) or from cadavers (e.g., lyophilized and frozen bone). In 
some cases, immunosuppressive drugs are necessary to prevent rejection of the transplanted 
organ, or other medications that minimize possible microbial contamination [1]. In addition, 
transplants have the disadvantage of raising a series of ethical and even religious issues. In 
contrast, devices developed to serve as implants do not present many of the problems 
reported above and are designed to act at the recipient tissue interface in the organism, 
interacting with these tissues [1, 2]. 
Biomaterials were first developed to remain inert in the organism. Thus, studies were aimed 
at investigating how to prevent or minimize undesired tissue reactions. At present, new 
materials are designed to elicit an effective interaction with tissues, provoking physiological 
responses such as cell growth and/or differentiation at the site of implantation [3]. 
Significant advances have been made over the past decades in the understanding of the 
mechanisms underlying the interaction of animal cells with their natural environment, i.e., 
the extracellular matrix, as well as of the influence of this matrix on cell growth and 
differentiation [4, 5]. This knowledge is frequently being used for the development of 
polymers that mimic the characteristics of extracellular matrix, thus playing an active role in 
tissue restoration. 
The biomaterials used can be classified into permanent or temporary materials [6]. 
Permanent materials are used to replace damaged tissue for an undetermined period of time 
and are therefore designed to retain their mechanical and physicochemical properties for 
prolonged periods of time [6]. These types of devices are commonly employed 
experimentally as prostheses, replacing damaged joints, heart valves and intraocular lenses, 
among others. On the other hand, in some situations the support only needs to fill the 
damaged region temporarily until tissue recomposition is completed, or guides the 
regeneration process. Temporary biomaterials are an alternative in this case. 
“Biodegradable” is a term that can be applied to polymers and solid devices that undergo 
dispersion in vivo as a result of macromolecular degradation, but without elimination of 
products and subproducts by the organism [7]. Biodegradable polymers can be attacked by 
biological elements in such a way that the integrity of the system is affected, forming 
fragments and other degradation products that can be removed from the site of action but 
not necessarily from the organism. “Bioabsorbable” is a term that can be applied to 
polymeric materials and devices that dissolve in body fluids without breakdown of the 
macromolecular chain or a reduction in molecular mass [7]. One example is the slow 
dissolution of soluble implants in organic fluids. “Bioresorbable” materials are polymers 
and solid devices that degrade through a reduction in size and that are resorbed in vivo, i.e., 
materials that are eliminated by metabolic pathways of the organism. Bioresorption is a 
concept that reflects the complete elimination of the material and of degradation products 
(compounds of low molar mass) in the absence of residual side effects [7]. The term 
“bioresorption” is applied when complete elimination occurs. A polymer can be 
bioresorbable if its macromolecules are excreted [7,8]. Bioresorbable polymeric materials are 
preferentially used as temporary devices [6]. 
2. Bioresorbable devices as cell culture substrates 
A wide variety of temporary devices have been employed in biological systems, with the 
most widely used materials being based on -hydroxy acid-derived polyesters, such as 
poly(L-lactic acid) (PLLA), poly(D-lactic acid) (PDLA), poly(DL-lactic acid) (PDLLA), 
poly(glycolic acid) (PGA), and polycaprolactone (PCL) [6,8]. During degradation, the 
polymer is broken down into smaller units by simple hydrolysis and its degradation 
products are eliminated from the body by metabolic pathways, such as the citric acid cycle, 
or directly by renal excretion (see Figure 1) [9-12]. 
Although the degradation of bioresorbable polymers mainly occurs by simple hydrolysis, 
there are reports in the literature indicating that degradation of PGA and PLLA, at least in 
part, is also mediated by enzymes [12,13]. Figure 1 is a schematic presentation of the 
degradation of PLLA by hydrolysis [8]. The elimination routes of the degradation products 
of some polyesters are shown in Figure 2. 
 
 Fig. 1. Degradation of poly(-hydroxy acids) by hydrolysis (From Barbanti et al. [8], with 
authorization). 
 
Other bioresorbable polymers used are polyhydroxyalcanoates, polyesters produced by 
microorganisms. These compounds find applications as raw materials of different devices in 
the areas of biomedicine and tissue engineering [14]. Polyhydroxyalcanoates include poly(3-
hydroxybutyrate) (PHB), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolymer 
(PHBV), poly(4-hydroxybutyrate) (P4HB), poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) 
copolymer (PHBHHx), and poly(3-hydroxyoctanoate) (PHO). These compounds have been 
used for the development of sutures, devices to guide tissue repair, heart implants, 
orthopedic pins, stents, tubules for nerve regeneration, and membranes for skin 
regeneration [14]. The use of PLLA/PHBV blends has appeared as a new proposal in the 
literature. The biological evaluation of this compound is relevant for tissue engineering 
[15,16]. 
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 Fig. 2. Routes of degradation and excretion of some polyesters: poly(p-dioxane) (PDS), 
poly(glycolic acid) (PGA), poly(lactic acid) (PLA), and poly(hydroxybutyrate) (PHB). 
 
3. Cell adhesion on polymer substrates 
Normally, cell adhesion to the substrate is necessary for a good polymer-cell interaction. 
Although the substrate does not need to present extracellular matrix-like characteristics for 
cell adhesion to occur, physicochemical similarity is often desired when the aim is to 
promote cell differentiation or a more effective interaction of a certain polymer at the 
implantation site [2-4,17]. Thus, polymers presenting physicochemical and/or mechanical 
properties as close as possible to those of the tissues into which they will be implanted are 
currently being developed. These properties include an adequate balance between 
hydrophilicity/hydrophobicity, electrical charge distribution, hardness, elasticity, and 
strength [18]. 
A relationship exists between hydrophilicity and cell adhesion. Among other parameters, 
more hydrophilic substrates tend to provide a better interaction with cells [19-21]. The 
relationship between cell adhesion and polar groups on the material surface has been 
demonstrated for polystyrene. Adhesion of cells was found to increase with increasing 
polarity of the substrate [22]. In a study investigating hepatic cells cultured on different 
substrates, cell adhesion increased proportionally to the surface energy of the growth 
membranes. Adhesion was even higher in the presence of serum proteins adsorbed to the 
substrates and the metabolic activity of hepatic cells increased on hydrophilic membranes 
[23]. Other studies demonstrated a relationship between wettability and cell adhesion. Lee et 
al. [24] prepared a wettability gradient on polyethylene surfaces to investigate the 
interaction of different types of cells (Chinese hamster ovary cells, fibroblasts and 
endothelial cells) with fetal bovine serum proteins, in terms of surface 
hydrophilicity/hydrophobicity. Better adhesion, spreading and growth of cells were 
observed on surfaces with moderate hydrophilicity. Maximum adhesion was found on 
substrates with a water contact angle of approximately 57º, irrespective of the type of cell used. 
Serum proteins also adhered better to substrates presenting moderate hydrophilicity [24]. 
Thus, cell adhesion is an extremely important factor for biomaterials research. Only after 
adhesion do the cells initiate the process of spreading, division and production of new 
extracellular matrix [18,19]. Cell spreading is a complex process that involves modifications 
in cell morphology as a consequence of alterations in the cytoskeleton, thus improving 
interaction with the substrate. These modifications are shown in Figure 3. 
 
  
Fig. 3. Spreading of Vero cells on type I collagen gel. Round cells are observed during 
inoculation, a morphology that is adequate for the state of being in suspension. After 
adhesion, the cells start their interaction with the substrate. Note the onset of the 
phenomenon known as spreading in (A), which is characterized by modifications in the 
cytoskeleton and, consequently, in cell morphology as a result of interactions with the 
growth surface, with the cell flattening on the growth surface. (B) A cell spread on the 
substrate. Magnification bar: A = 15 µm; B = 10 µm (From Santos Jr and Wada [5], with 
authorization). 
 
Good integration of the biomaterial with cells or tissues also depends on the structure of the 
devices itself. Our experience agrees with literature data indicating that porous materials 
promote cell growth and induce the production of extracellular matrix components by the 
cells [21,25]. A uniform distribution and pore interconnections are important to facilitate the 
formation of tissues in the form of an organized network, with a wide range of applications 
in tissue reconstruction [3,26,27]. In vivo, porosity and pore interconnection are essential for 
the proliferation of vessels, facilitating tissue nutrition around the implant. In this respect, 
different types of scaffolds containing PLLA have been developed and tested as substrates 
for cell growth [3]. Kwon et al. [28] evaluated nano- and microfibrous scaffolds with 
different compositions of PLLA, PCL and poly(L-lactic acid-co-caprolactone) (PLCL) (70/30, 
50/50 and 30/70) as cell culture substrate. Human umbilical vein endothelial cells were 
found to adhere and proliferate well on the small-diameter fiber scaffolds (0.3 to 1.2 mm in 
diameter), whereas a marked reduction in cell adhesion and spreading, as well as a low 
proliferative capacity, was observed for large-diameter fiber scaffolds (about 7.0 mm).  
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Studies from our group have shown an initially slow adhesion to PLLA and PHBV scaffolds 
[21,25]. This finding does not necessarily indicate that the material tested would not be 
useful for tissue engineering. Mann et al. [29] showed that in the case of slow adhesion the 
materials may stimulate the early production of extracellular matrix components, permitting 
cell growth and proliferation. Our observations agree with these authors [21,25]. The 
extracellular matrix exerts a marked influence on the migration, proliferation and 
differentiation of cells cultured on biomaterials. Gunawan and coworkers [30] demonstrated 
the influence of the density of extracellular matrix components on the migration of rat 
intestinal cells (IEC-6 cells). The cells migrated in the direction of the gradient formed, with 
the demonstration of the particular role of laminin in this process. 
Nevertheless, there is a trend to change the architecture of cell culture substrates used for 
tissue engineering [31]. The aim of these surface modifications is to improve the interaction 
with cells both in vitro and in vivo. With respect to cell cultures, increased cell interaction 
means to favor the initial interaction of cells with the substrate, i.e., to increase adhesion. In 
a recent study, nanofibrous PLLA scaffolds were fabricated and tested. The surface 
modifications introduced significantly increased cell adhesion and spreading. In addition, 
cell proliferation was maintained for more than 2 weeks and the modifications also 
increased the production of extracellular matrix components [32]. 
The surface properties of biomaterials can be altered in such a way as to make them more 
adequate for biomedical applications. The most commonly used techniques are chemical 
etching, gas plasma treatment and electron beam radiation [33]. Among these techniques, 
plasma treatment is particularly versatile because the modification is restricted to the 
surface without compromising the material properties as a whole. Plasma treatment can be 
used to modify the polymer surface in a nonspecific manner by introducing a variety of 
functional groups depending on the type of gas used [34,35]. Plasma is considered to be the 
fourth state of matter and consists of highly excited states of atoms, molecules, ions and 
radicals obtained from gases elevated to excited stages by radiofrequency, microwaves or 
electron discharge [35]. Thus, surface modification by plasma treatment is an economic and 
effective technique for biomaterials and is gaining space in the area of biomedicine, with its 
application becoming more frequent. The main advantage of plasma treatment is its 
capacity to modify the surface of materials, making them more biocompatible or permitting 
them to more closely mimic tissue without altering their properties. As a consequence, this 
technique permits a high degree of quality control, offering reliability and reproducing what 
would be difficult to achieve with conventional techniques. Another advantage of plasma 
treatment is that it renders the surface sterile by destruction of microorganisms such as 
bacteria and viruses and is therefore useful for biomedical devices, surgical instruments, 
tissue engineering and clinical applications [35]. Our experience shows that plasma 
treatment increases cell adhesion to PHBV matrices, rendering these scaffolds more 
receptive to cell growth [36]. 
Nakagawa et al. [37] submitted PLLA samples to plasma treatment in a CO2 atmosphere and 
observed an increase in the hydrophilicity of the membrane. The cell response was also 
highly satisfactory for membranes submitted to plasma treatment compared to controls. 
Plasma treatment provided better cell adhesion and proliferation, although the authors had 
used short-term cell cultures (up to 3 days only). Ryu and coworkers [38] submitted 
poly(D,L-lactic acid-co-glycolic acid) (PLGA) membranes to plasma treatment. In that study, 
the PLGA surface was modified in order to increase the interaction of cells with the material 
surface. The results showed that the surface modifications increased hydrophilicity and cell 
adhesion and proliferation. 
Several studies have been conducted to develop materials with biomimetic characteristics. 
Surface modification of biomaterials using bioactive molecules is a relatively simple 
approach to produce biomimetic materials. Long chains of extracellular matrix proteins such 
as fibronectin, vitronectin and laminin have been used for this purpose. Biomaterials coated 
with these proteins normally present increased cell adhesion and proliferation [31,39]. 
Peptides have also been used for surface modifications, with the most frequently used 
sequence being Arg-Gly-Asp (RGD), the binding sequence derived from fibronectin and 
laminin. Other peptide sequences such as Tyr-Ile-Gly-Ser-Arg (YIGSR), Arg-Glu-Asp-Val 
(REDV) and Ile-Lys-Val-Ala-Val (IKVAV) have also been employed for substrates such as 
quartz, glass, metal oxide and polymers [31,39]. 
Porous PDLA and PLLA substrates containing 2-methacryloyloxyethyl phosphorylcholine 
(MPC) and n-butyl methacrylate (BMA) were investigated regarding their capacity to 
interact with fibroblasts. MPC is an analog of phosphatidylcholine, a typical lipid of the 
plasma membrane of cells. The results obtained were quite interesting. The number of 
adhered cells was correlated with PDLA and PLLA content, with the cells presenting a good 
pattern of adhesion and migrating into the substrate within only 24 h of culture. 
Furthermore, cell morphology was influenced by the contact with MPC [40], with the 
addition of MPC rendering the PDLA and PLLA scaffolds more receptive to the initial 
interaction with cells. 
Despite promising results, some investigators have reported discrepancies in the findings 
regarding the addition of bioactive molecules to growth surfaces. In this respect, an 
interesting study was conducted by Harnett et al. [41] who coated various biomaterials with 
different adhesion molecules such as fibronectin, polylysine, polyornithine and collagen in 
order to evaluate changes in surface free energy and the hydrophilicity/hydrophobicity 
balance. Only fibronectin promoted a homogenous coating for all substrates tested, 
producing a monopolar acid surface, whereas polylysine, polyornithine and collagen 
coatings produced hydrophobic or hydrophilic surfaces depending on the underlying 
substrate they were coated on. 
 
4. Tissue engineering and bioresorbable polymers 
Once cell adhesion is established, the material tested is studied as a cell carrier in procedures 
aimed at the restoration of damaged tissues. Tissue engineering can be understood as the 
application of the principles of exact sciences to tissue creation and repair. Three general 
strategies have been adopted to obtain new tissues [17]: 
1) Use of autogenous cells i.e., cells isolated from the individual himself; isogeneic cells, i.e., 
cells obtained from different individuals which, however, are genetically identical or belong 
to the same species; allogeneic cells,  i.e., cells isolated from different individuals of the same 
species, or xenogeneic cells, i.e., cells obtained from different species [42]. These cells are 
expanded in culture and implanted into the body by infusion methods. However, 
limitations of this strategy include the limited capacity of the cells to maintain their 
differentiated characteristics in vitro, the difficulty in sufficiently expanding some cells in 
culture (for example, hepatic and neural cells cannot be expanded in adequate numbers for 
clinical use), and immunological rejection when allogeneic and xenogeneic cells are used.  
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functional groups depending on the type of gas used [34,35]. Plasma is considered to be the 
fourth state of matter and consists of highly excited states of atoms, molecules, ions and 
radicals obtained from gases elevated to excited stages by radiofrequency, microwaves or 
electron discharge [35]. Thus, surface modification by plasma treatment is an economic and 
effective technique for biomaterials and is gaining space in the area of biomedicine, with its 
application becoming more frequent. The main advantage of plasma treatment is its 
capacity to modify the surface of materials, making them more biocompatible or permitting 
them to more closely mimic tissue without altering their properties. As a consequence, this 
technique permits a high degree of quality control, offering reliability and reproducing what 
would be difficult to achieve with conventional techniques. Another advantage of plasma 
treatment is that it renders the surface sterile by destruction of microorganisms such as 
bacteria and viruses and is therefore useful for biomedical devices, surgical instruments, 
tissue engineering and clinical applications [35]. Our experience shows that plasma 
treatment increases cell adhesion to PHBV matrices, rendering these scaffolds more 
receptive to cell growth [36]. 
Nakagawa et al. [37] submitted PLLA samples to plasma treatment in a CO2 atmosphere and 
observed an increase in the hydrophilicity of the membrane. The cell response was also 
highly satisfactory for membranes submitted to plasma treatment compared to controls. 
Plasma treatment provided better cell adhesion and proliferation, although the authors had 
used short-term cell cultures (up to 3 days only). Ryu and coworkers [38] submitted 
poly(D,L-lactic acid-co-glycolic acid) (PLGA) membranes to plasma treatment. In that study, 
the PLGA surface was modified in order to increase the interaction of cells with the material 
surface. The results showed that the surface modifications increased hydrophilicity and cell 
adhesion and proliferation. 
Several studies have been conducted to develop materials with biomimetic characteristics. 
Surface modification of biomaterials using bioactive molecules is a relatively simple 
approach to produce biomimetic materials. Long chains of extracellular matrix proteins such 
as fibronectin, vitronectin and laminin have been used for this purpose. Biomaterials coated 
with these proteins normally present increased cell adhesion and proliferation [31,39]. 
Peptides have also been used for surface modifications, with the most frequently used 
sequence being Arg-Gly-Asp (RGD), the binding sequence derived from fibronectin and 
laminin. Other peptide sequences such as Tyr-Ile-Gly-Ser-Arg (YIGSR), Arg-Glu-Asp-Val 
(REDV) and Ile-Lys-Val-Ala-Val (IKVAV) have also been employed for substrates such as 
quartz, glass, metal oxide and polymers [31,39]. 
Porous PDLA and PLLA substrates containing 2-methacryloyloxyethyl phosphorylcholine 
(MPC) and n-butyl methacrylate (BMA) were investigated regarding their capacity to 
interact with fibroblasts. MPC is an analog of phosphatidylcholine, a typical lipid of the 
plasma membrane of cells. The results obtained were quite interesting. The number of 
adhered cells was correlated with PDLA and PLLA content, with the cells presenting a good 
pattern of adhesion and migrating into the substrate within only 24 h of culture. 
Furthermore, cell morphology was influenced by the contact with MPC [40], with the 
addition of MPC rendering the PDLA and PLLA scaffolds more receptive to the initial 
interaction with cells. 
Despite promising results, some investigators have reported discrepancies in the findings 
regarding the addition of bioactive molecules to growth surfaces. In this respect, an 
interesting study was conducted by Harnett et al. [41] who coated various biomaterials with 
different adhesion molecules such as fibronectin, polylysine, polyornithine and collagen in 
order to evaluate changes in surface free energy and the hydrophilicity/hydrophobicity 
balance. Only fibronectin promoted a homogenous coating for all substrates tested, 
producing a monopolar acid surface, whereas polylysine, polyornithine and collagen 
coatings produced hydrophobic or hydrophilic surfaces depending on the underlying 
substrate they were coated on. 
 
4. Tissue engineering and bioresorbable polymers 
Once cell adhesion is established, the material tested is studied as a cell carrier in procedures 
aimed at the restoration of damaged tissues. Tissue engineering can be understood as the 
application of the principles of exact sciences to tissue creation and repair. Three general 
strategies have been adopted to obtain new tissues [17]: 
1) Use of autogenous cells i.e., cells isolated from the individual himself; isogeneic cells, i.e., 
cells obtained from different individuals which, however, are genetically identical or belong 
to the same species; allogeneic cells,  i.e., cells isolated from different individuals of the same 
species, or xenogeneic cells, i.e., cells obtained from different species [42]. These cells are 
expanded in culture and implanted into the body by infusion methods. However, 
limitations of this strategy include the limited capacity of the cells to maintain their 
differentiated characteristics in vitro, the difficulty in sufficiently expanding some cells in 
culture (for example, hepatic and neural cells cannot be expanded in adequate numbers for 
clinical use), and immunological rejection when allogeneic and xenogeneic cells are used.  
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2) Tissue culture for subsequent implantation and replacement of sick or damaged tissues. 
The most common example used in clinical practice is skin grafts [43]. The main advantage 
of this strategy is its high biocompatibility and biofunctionality. However, this strategy 
presents the same disadvantages as described above. 
3) Use of substances that induce the regeneration of damaged tissue. The success of this 
strategy depends on the large-scale purification and production of appropriate signal 
molecules such as growth factors and adhesion molecules. The proliferation of many cell 
types (which may induce the formation of a new tissue) depends on a combination of 
various growth factors that are highly specific proteins. Some growth factors can be released 
slowly from polymeric capsules and may stimulate the growth of damaged tissue [44]. In 
contrast, adhesion molecules such as fibronectin, vitronectin and laminin are protein 
components of biological fluids and/or extracellular matrix that are adsorbed on the 
material surface and recognized by integrins (cell membrane receptors associated with the 
cytoskeleton) [4]. Integrins bind to the small domains of adhesion molecules [45], such as the 
RGD amino acid sequence of fibronectin and vitronectin or the YIGSR sequence of laminin. 
RGD and other oligopeptides have been incorporated into some biomaterials to stimulate 
adhesion and consequent cell proliferation. 
Autogenous or autograft implants are of special interest. This technique consists of the use 
of healthy cells derived from the patient himself who will receive the polymer implant. 
Autogenous implants have some advantages over organ transplants. Since the cell 
population isolated is expanded in vitro by cell culture, only a small number of donor cells is 
necessary for preparation of the implant. In addition, the use of autogenous cells avoids 
immunological problems such as rejections or allergic processes [3,42,46]. 
 
5. Cell growth and proliferation on bioresorbable polymers 
Bioresorbable devices have been used in vitro as a support for the growth and proliferation 
of different cell types. Endothelial cells have been shown to satisfactorily multiply on PLLA 
scaffolds in the absence of platelet activation [47,48]. Good adhesion to the material and an 
adequate multiplication rate were reported for NIH/3T3 mouse cells cultured on PHBV 
membranes. These parameters improved after the introduction of physicochemical 
modifications (change in polymer hydrophilicity) on the PHBV surface [49]. In another 
study, cell proliferation on a PHBV substrate continued to be similar to that observed for 
collagen sponges for up to 35 days of culture [50]. 
The capacity of a substrate to stimulate cell growth and proliferation is intimately related to 
its ability to absorb proteins. In a recent study, Zhu and coworkers [48] showed that coating 
of the surface of PLLA devices with free amine groups increases the spreading and 
proliferation of endothelial cells. Extracellular matrix proteins such as fibronectin, laminin 
and collagen have also been shown to stimulate the multiplication of cells on substrates 
used for tissue engineering [51]. We showed that Vero cells  produce extracellular matrix 
rich in fibronectin and collagen when cultured on dense or porous PLLA membranes, PHBV 
scaffolds or PLLA/PHBV blends of different proportions [21,25]. This finding may explain 
the observation of a significant proliferation rate despite the initially slow cell adhesion to 
these scaffolds [25,52]. 
6. Bioresorbable devices for cartilage engineering 
The use of bioresorbable materials for articular cartilage repair is currently being 
investigated. Cartilage is an avascular tissue which basically consists of two cell types, 
chondrocytes and chondroblasts. Chondrocytes produce an extracellular matrix that mainly 
consists of collagen and glycosaminoglycans. The proportion of these components depends 
on the type of cartilaginous tissue [53]. Once damaged, cartilage presents little or no 
regenerative capacity and certain injuries may progress to severe degenerative joint diseases 
[46,53]. In addition to the fact that the mechanisms underlying the formation of articular 
cartilage are still unclear, there are few alternative clinical procedures to the replacement of 
joints with prostheses that can fill small defects resulting from trauma or degenerative 
diseases. Current treatments for articular cartilage engineering include 1) the creation of a 
defect by wear or perforation to permit the migration of progenitor cells; 2) arthroscopy; 3) 
autografts; 4) transplantation of perichondrium and periosteum to introduce 
undifferentiated cells with a chondrogenic potential; 5) autogenous cell transplants 
(chondrocytes or undifferentiated cells) previously expanded in vitro and reinjected as an 
autogenous periosteal graft that is able to maintain both chondrogenesis and osteogenesis 
[54]. Studies on cartilage engineering that combine different materials in the production of 
scaffolds used as a support for chondrogenic cells are necessary. In this respect, there is an 
intense search for materials that mimic the biomechanical behavior of articular cartilage and 
thus can be applied to joint repair [46]. Some polymeric materials including both temporary 
and permanent polymers are investigated for this application. Bioresorbable materials 
studied for their use as temporary cartilage matrix include PLLA and PGA polymers and 
their copolymers and blends.  
Chondrocytes cultured on a fibrous PGA matrix and porous PLLA membranes have been 
studied [55]. The results showed the neoformation of cartilage tissue comparable to that 
observed for chondrocytes cultured on collagen substrates obtained from articular cartilage. 
Under these conditions, chondrocytes continued to grow on these polymers for up to 6 
months, maintaining the shape of the original device and producing a tissue with 
characteristics similar to those of cartilage, including the synthesis of glycosaminoglycans 
and types I and II collagen [55]. In addition, it was observed that cartilage cells cultured on 
polyesters such as PLLA and PGA tend to show increased synthesis of proteoglycans and 
collagen when compared to cells cultured on collagen matrix [56]. Puelacher et al. [57] 
studied the in vitro and in vivo growth of chondrocytes on PGA and PLLA scaffolds that 
simulated the morphology of human nasal cartilage. The authors observed the formation of 
hyaline-like cartilage on these substrates. The experimental results indicate that, once 
improved, these tissue reconstruction techniques have potential applications in orthopedic, 
plastic and reconstructive and craniomaxillofacial surgery. In addition, the formation of 
hyaline-like cartilage was observed after 6 weeks when perichondrial cells were cultured on 
PLLA membranes and implanted into the femoral condyle of rabbits [55,58]. 
A study of cells obtained from human articular cartilage and maintained in culture on 
devices consisting of different bioresorbable polyesters showed that the process of adhesion 
was proportional to the hydrophilicity of the polymers. In addition, no variations in cell 
spreading were observed between the different biomaterials. Although the cells studied 
adhered less to the PLLA membranes when compared to PLGA, their proliferative capacity 
was better when grown on the PLLA membrane [59]. In addition, the production of 
cartilaginous matrix and type II collagen was found to be lower for human chondrocytes 
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2) Tissue culture for subsequent implantation and replacement of sick or damaged tissues. 
The most common example used in clinical practice is skin grafts [43]. The main advantage 
of this strategy is its high biocompatibility and biofunctionality. However, this strategy 
presents the same disadvantages as described above. 
3) Use of substances that induce the regeneration of damaged tissue. The success of this 
strategy depends on the large-scale purification and production of appropriate signal 
molecules such as growth factors and adhesion molecules. The proliferation of many cell 
types (which may induce the formation of a new tissue) depends on a combination of 
various growth factors that are highly specific proteins. Some growth factors can be released 
slowly from polymeric capsules and may stimulate the growth of damaged tissue [44]. In 
contrast, adhesion molecules such as fibronectin, vitronectin and laminin are protein 
components of biological fluids and/or extracellular matrix that are adsorbed on the 
material surface and recognized by integrins (cell membrane receptors associated with the 
cytoskeleton) [4]. Integrins bind to the small domains of adhesion molecules [45], such as the 
RGD amino acid sequence of fibronectin and vitronectin or the YIGSR sequence of laminin. 
RGD and other oligopeptides have been incorporated into some biomaterials to stimulate 
adhesion and consequent cell proliferation. 
Autogenous or autograft implants are of special interest. This technique consists of the use 
of healthy cells derived from the patient himself who will receive the polymer implant. 
Autogenous implants have some advantages over organ transplants. Since the cell 
population isolated is expanded in vitro by cell culture, only a small number of donor cells is 
necessary for preparation of the implant. In addition, the use of autogenous cells avoids 
immunological problems such as rejections or allergic processes [3,42,46]. 
 
5. Cell growth and proliferation on bioresorbable polymers 
Bioresorbable devices have been used in vitro as a support for the growth and proliferation 
of different cell types. Endothelial cells have been shown to satisfactorily multiply on PLLA 
scaffolds in the absence of platelet activation [47,48]. Good adhesion to the material and an 
adequate multiplication rate were reported for NIH/3T3 mouse cells cultured on PHBV 
membranes. These parameters improved after the introduction of physicochemical 
modifications (change in polymer hydrophilicity) on the PHBV surface [49]. In another 
study, cell proliferation on a PHBV substrate continued to be similar to that observed for 
collagen sponges for up to 35 days of culture [50]. 
The capacity of a substrate to stimulate cell growth and proliferation is intimately related to 
its ability to absorb proteins. In a recent study, Zhu and coworkers [48] showed that coating 
of the surface of PLLA devices with free amine groups increases the spreading and 
proliferation of endothelial cells. Extracellular matrix proteins such as fibronectin, laminin 
and collagen have also been shown to stimulate the multiplication of cells on substrates 
used for tissue engineering [51]. We showed that Vero cells  produce extracellular matrix 
rich in fibronectin and collagen when cultured on dense or porous PLLA membranes, PHBV 
scaffolds or PLLA/PHBV blends of different proportions [21,25]. This finding may explain 
the observation of a significant proliferation rate despite the initially slow cell adhesion to 
these scaffolds [25,52]. 
6. Bioresorbable devices for cartilage engineering 
The use of bioresorbable materials for articular cartilage repair is currently being 
investigated. Cartilage is an avascular tissue which basically consists of two cell types, 
chondrocytes and chondroblasts. Chondrocytes produce an extracellular matrix that mainly 
consists of collagen and glycosaminoglycans. The proportion of these components depends 
on the type of cartilaginous tissue [53]. Once damaged, cartilage presents little or no 
regenerative capacity and certain injuries may progress to severe degenerative joint diseases 
[46,53]. In addition to the fact that the mechanisms underlying the formation of articular 
cartilage are still unclear, there are few alternative clinical procedures to the replacement of 
joints with prostheses that can fill small defects resulting from trauma or degenerative 
diseases. Current treatments for articular cartilage engineering include 1) the creation of a 
defect by wear or perforation to permit the migration of progenitor cells; 2) arthroscopy; 3) 
autografts; 4) transplantation of perichondrium and periosteum to introduce 
undifferentiated cells with a chondrogenic potential; 5) autogenous cell transplants 
(chondrocytes or undifferentiated cells) previously expanded in vitro and reinjected as an 
autogenous periosteal graft that is able to maintain both chondrogenesis and osteogenesis 
[54]. Studies on cartilage engineering that combine different materials in the production of 
scaffolds used as a support for chondrogenic cells are necessary. In this respect, there is an 
intense search for materials that mimic the biomechanical behavior of articular cartilage and 
thus can be applied to joint repair [46]. Some polymeric materials including both temporary 
and permanent polymers are investigated for this application. Bioresorbable materials 
studied for their use as temporary cartilage matrix include PLLA and PGA polymers and 
their copolymers and blends.  
Chondrocytes cultured on a fibrous PGA matrix and porous PLLA membranes have been 
studied [55]. The results showed the neoformation of cartilage tissue comparable to that 
observed for chondrocytes cultured on collagen substrates obtained from articular cartilage. 
Under these conditions, chondrocytes continued to grow on these polymers for up to 6 
months, maintaining the shape of the original device and producing a tissue with 
characteristics similar to those of cartilage, including the synthesis of glycosaminoglycans 
and types I and II collagen [55]. In addition, it was observed that cartilage cells cultured on 
polyesters such as PLLA and PGA tend to show increased synthesis of proteoglycans and 
collagen when compared to cells cultured on collagen matrix [56]. Puelacher et al. [57] 
studied the in vitro and in vivo growth of chondrocytes on PGA and PLLA scaffolds that 
simulated the morphology of human nasal cartilage. The authors observed the formation of 
hyaline-like cartilage on these substrates. The experimental results indicate that, once 
improved, these tissue reconstruction techniques have potential applications in orthopedic, 
plastic and reconstructive and craniomaxillofacial surgery. In addition, the formation of 
hyaline-like cartilage was observed after 6 weeks when perichondrial cells were cultured on 
PLLA membranes and implanted into the femoral condyle of rabbits [55,58]. 
A study of cells obtained from human articular cartilage and maintained in culture on 
devices consisting of different bioresorbable polyesters showed that the process of adhesion 
was proportional to the hydrophilicity of the polymers. In addition, no variations in cell 
spreading were observed between the different biomaterials. Although the cells studied 
adhered less to the PLLA membranes when compared to PLGA, their proliferative capacity 
was better when grown on the PLLA membrane [59]. In addition, the production of 
cartilaginous matrix and type II collagen was found to be lower for human chondrocytes 
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cultured on PLLA membranes compared to those grown on PLGA membranes. On the other 
hand, cells grown on PLLA scaffolds presented a greater capacity of synthesizing type I 
collagen [60]. Interesting results were also obtained with PLLA scaffolds used for meniscus 
reconstruction. Porous implants were found to guide vascular growth into the injury region 
[61]. Canine meniscus reconstruction using lactic acid/-caprolactone copolymers have also 
been reported [62]. These results demonstrate that the principles of tissue engineering 
employing bioresorbable materials are a promising study area and certainly will yield 
significant results in the near future. 
In an attempt to better mimic the natural environment of cartilage cells, Takagi and 
coworkers [63] developed a scaffold consisting of collagen and a copolymer mesh of PLLA 
and PLGA. Glucuronic acid is one of the components of glycosaminoglycans found in the 
extracellular matrix of tissues. The authors showed that cartilage cells cultured inside the 
scaffold consumed glucose from the culture medium and produced typical extracellular 
matrix components of cartilage tissue. Within this context, another study compared 
hyaluronic acid scaffolds and polyester scaffolds with different degradation rates [64]. The 
study showed that the degradation rate of the scaffolds is critical for the cartilage repair 
process. Cartilage formation was slow with dissolution of the materials, although presenting 
more cracks and discontinuities. Wang et al. [65] tested scaffolds of different origins, such as 
poly(L-lactide), poly(D,L-lactide) and collagen-hydroxyapatite, for the in vitro production of 
cartilage. Porcine chondrocytes were seeded onto the scaffolds. After 15 weeks of culture, a 
layer of viable neo-cartilage was produced on each material, with the collagen-
hydroxyapatite constructs yielding better results in terms of cell viability and integration. 
Another approach was the use of a gelatin scaffold obtained from demineralized bone 
matrix inoculated with rabbit chondrocytes. Neoformation of hyaline-like cartilage was 
demonstrated [66]. 
In a well-conceived experiment, chondrocytes were cultured on PLLA microspheres in a 
bioreactor. In addition, the surface of the microspheres was modified by the addition of 
RGD peptides, small repetitive sequences of the amino acids arginine (Arg or R), glycine 
(Gly or G) and aspartate (Asp or D) which are known to stimulate cell adhesion. PLLA 
degradation was determined after different periods of time (7, 14, 21, 28, 35, 49 and 56 days). 
The authors observed that the materials continued to be stable to support cell growth after 
the periods studied. The use of a bioreactor resulted in a significant increase in the number 
of cells cultured on the biomaterials and the devices studied showed a good capacity to 
stimulate cell adhesion and proliferation. The authors also observed the formation of 
microaggregates, a finding that might indicate the production of extracellular matrix [67]. 
In another study, human mesenchymal stem cells were cultured on a PLDLA scaffold. This 
construct was maintained in chondrogenic medium and the other end was then loaded with 
cells of the same origin but previously induced to undergo osteogenesis. This system was 
then cultured under conditions able to maintain both chondrogenesis and osteogenesis, thus 
producing in vitro a hybrid osteochondral construct [68]. Taken together, these results are 
promising but the search for a polymeric material that better mimics the function of articular 
cartilage still continues. 
 
7. Bioresorbable devices for bone tissue engineering 
Bone is a natural tissue which consists of an organic component (mainly collagen) and a 
mineral component composed of hydroxyapatite. Reconstruction of long bone defects is a 
clinical challenge. Normally, multiple surgeries are required to restore the structure and 
function of the damage site. The development of tissue engineering techniques has led to the 
use of new procedures for bone restoration. Polymeric materials may serve as a support for 
cell growth, permitting the penetration of blood vessels, and even exert morphogenetic 
activity in some cases. In the case of bioresorbable polymers, the materials are often 
enriched with hydroxyapatite, growth factors, bone morphogenetic proteins (BMPs) and 
other bone elements, a fact that renders them highly effective in the stimulation of bone 
neoformation in the damaged areas [10]. 
Transplants consisting of different types of isolated cells cultured on PLLA and PGA 
scaffolds have been investigated as temporary substitutes of damaged tissue portions [17]. 
Implantation of PLGA copolymers into bone resulted in bioresorption of the material and 
concomitant bone neoformation at the site of the implant. An additional advantage of PLGA 
is that its complete degradation is variable and may occur within weeks or years depending 
on the polyester ratio present in the copolymers [69]. 
Osteoblastic cells cultured on PLLA, PGA and PLGA films presented a satisfactory pattern 
of cell adhesion and spreading, in addition to the ability to grow and proliferate on the 
substrate. Furthermore, cells grown on these polymers presented increased alkaline 
phosphatase activity, a marker of osteoblast differentiation, and increased synthesis of 
collagen I [70]. Similar results were obtained when osteoblasts were cultured on PLGA 
scaffolds. In that case, mineralization of the bone matrix produced was also observed 
[71,72]. Interestingly, even bone marrow cells cultured on porous PLGA scaffolds and 
implanted into the rat mesentery were able to initiate ectopic bone formation [71]. 
It has been postulated that porous materials implanted in vivo present a better integration 
with the recipient tissue. Disagreement still exists regarding the ideal diameter of the pores 
for tissue growth. In vitro, low porosity stimulates osteogenesis, suppressing cell 
proliferation by forcing cell aggregation. On the other hand, in vivo, a higher porosity with 
larger pores promotes bone growth. However, these factors result in low mechanical 
properties and, therefore, a functional limit exists for porosity and pore size [73]. On the 
basis of these studies, a minimum pore size of approximately 100 µm was established 
considering cell size, migration requirements and transport. In vitro and in vivo results 
suggest pore sizes and pore interconnections > 300 µm to facilitate vascularization of the 
graft. Some investigators recommend diameter variations of 300 to 400 µm, whereas others 
propose even wider intervals of 200 to 400 µm [74]. Thus, the macrostructure (pre-existing 
macroporosity), microstructure (microporosity, enhanced surface microroughness or 
microtexture) and chemical composition of the material play an important role in 
osteoinduction guided by the biomaterial in vitro. In addition, the model used for in vivo 
study may also markedly influence the results. Osteoinduction is only occasionally observed 
in mice and rats, whereas the same material induces bone formation reproducibly in goats 
and dogs [75]. 
Another interesting approach is the adsorption of factors that stimulate cell differentiation 
on polymer surfaces. In 1965, ectopic bone formation was demonstrated after implantation 
of demineralized bone matrix into muscles of rabbits, rats, mice and guinea pigs [76]. A 
protein, called bone morphogenetic protein (BMP), was found to be involved in the cascade 
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cultured on PLLA membranes compared to those grown on PLGA membranes. On the other 
hand, cells grown on PLLA scaffolds presented a greater capacity of synthesizing type I 
collagen [60]. Interesting results were also obtained with PLLA scaffolds used for meniscus 
reconstruction. Porous implants were found to guide vascular growth into the injury region 
[61]. Canine meniscus reconstruction using lactic acid/-caprolactone copolymers have also 
been reported [62]. These results demonstrate that the principles of tissue engineering 
employing bioresorbable materials are a promising study area and certainly will yield 
significant results in the near future. 
In an attempt to better mimic the natural environment of cartilage cells, Takagi and 
coworkers [63] developed a scaffold consisting of collagen and a copolymer mesh of PLLA 
and PLGA. Glucuronic acid is one of the components of glycosaminoglycans found in the 
extracellular matrix of tissues. The authors showed that cartilage cells cultured inside the 
scaffold consumed glucose from the culture medium and produced typical extracellular 
matrix components of cartilage tissue. Within this context, another study compared 
hyaluronic acid scaffolds and polyester scaffolds with different degradation rates [64]. The 
study showed that the degradation rate of the scaffolds is critical for the cartilage repair 
process. Cartilage formation was slow with dissolution of the materials, although presenting 
more cracks and discontinuities. Wang et al. [65] tested scaffolds of different origins, such as 
poly(L-lactide), poly(D,L-lactide) and collagen-hydroxyapatite, for the in vitro production of 
cartilage. Porcine chondrocytes were seeded onto the scaffolds. After 15 weeks of culture, a 
layer of viable neo-cartilage was produced on each material, with the collagen-
hydroxyapatite constructs yielding better results in terms of cell viability and integration. 
Another approach was the use of a gelatin scaffold obtained from demineralized bone 
matrix inoculated with rabbit chondrocytes. Neoformation of hyaline-like cartilage was 
demonstrated [66]. 
In a well-conceived experiment, chondrocytes were cultured on PLLA microspheres in a 
bioreactor. In addition, the surface of the microspheres was modified by the addition of 
RGD peptides, small repetitive sequences of the amino acids arginine (Arg or R), glycine 
(Gly or G) and aspartate (Asp or D) which are known to stimulate cell adhesion. PLLA 
degradation was determined after different periods of time (7, 14, 21, 28, 35, 49 and 56 days). 
The authors observed that the materials continued to be stable to support cell growth after 
the periods studied. The use of a bioreactor resulted in a significant increase in the number 
of cells cultured on the biomaterials and the devices studied showed a good capacity to 
stimulate cell adhesion and proliferation. The authors also observed the formation of 
microaggregates, a finding that might indicate the production of extracellular matrix [67]. 
In another study, human mesenchymal stem cells were cultured on a PLDLA scaffold. This 
construct was maintained in chondrogenic medium and the other end was then loaded with 
cells of the same origin but previously induced to undergo osteogenesis. This system was 
then cultured under conditions able to maintain both chondrogenesis and osteogenesis, thus 
producing in vitro a hybrid osteochondral construct [68]. Taken together, these results are 
promising but the search for a polymeric material that better mimics the function of articular 
cartilage still continues. 
 
7. Bioresorbable devices for bone tissue engineering 
Bone is a natural tissue which consists of an organic component (mainly collagen) and a 
mineral component composed of hydroxyapatite. Reconstruction of long bone defects is a 
clinical challenge. Normally, multiple surgeries are required to restore the structure and 
function of the damage site. The development of tissue engineering techniques has led to the 
use of new procedures for bone restoration. Polymeric materials may serve as a support for 
cell growth, permitting the penetration of blood vessels, and even exert morphogenetic 
activity in some cases. In the case of bioresorbable polymers, the materials are often 
enriched with hydroxyapatite, growth factors, bone morphogenetic proteins (BMPs) and 
other bone elements, a fact that renders them highly effective in the stimulation of bone 
neoformation in the damaged areas [10]. 
Transplants consisting of different types of isolated cells cultured on PLLA and PGA 
scaffolds have been investigated as temporary substitutes of damaged tissue portions [17]. 
Implantation of PLGA copolymers into bone resulted in bioresorption of the material and 
concomitant bone neoformation at the site of the implant. An additional advantage of PLGA 
is that its complete degradation is variable and may occur within weeks or years depending 
on the polyester ratio present in the copolymers [69]. 
Osteoblastic cells cultured on PLLA, PGA and PLGA films presented a satisfactory pattern 
of cell adhesion and spreading, in addition to the ability to grow and proliferate on the 
substrate. Furthermore, cells grown on these polymers presented increased alkaline 
phosphatase activity, a marker of osteoblast differentiation, and increased synthesis of 
collagen I [70]. Similar results were obtained when osteoblasts were cultured on PLGA 
scaffolds. In that case, mineralization of the bone matrix produced was also observed 
[71,72]. Interestingly, even bone marrow cells cultured on porous PLGA scaffolds and 
implanted into the rat mesentery were able to initiate ectopic bone formation [71]. 
It has been postulated that porous materials implanted in vivo present a better integration 
with the recipient tissue. Disagreement still exists regarding the ideal diameter of the pores 
for tissue growth. In vitro, low porosity stimulates osteogenesis, suppressing cell 
proliferation by forcing cell aggregation. On the other hand, in vivo, a higher porosity with 
larger pores promotes bone growth. However, these factors result in low mechanical 
properties and, therefore, a functional limit exists for porosity and pore size [73]. On the 
basis of these studies, a minimum pore size of approximately 100 µm was established 
considering cell size, migration requirements and transport. In vitro and in vivo results 
suggest pore sizes and pore interconnections > 300 µm to facilitate vascularization of the 
graft. Some investigators recommend diameter variations of 300 to 400 µm, whereas others 
propose even wider intervals of 200 to 400 µm [74]. Thus, the macrostructure (pre-existing 
macroporosity), microstructure (microporosity, enhanced surface microroughness or 
microtexture) and chemical composition of the material play an important role in 
osteoinduction guided by the biomaterial in vitro. In addition, the model used for in vivo 
study may also markedly influence the results. Osteoinduction is only occasionally observed 
in mice and rats, whereas the same material induces bone formation reproducibly in goats 
and dogs [75]. 
Another interesting approach is the adsorption of factors that stimulate cell differentiation 
on polymer surfaces. In 1965, ectopic bone formation was demonstrated after implantation 
of demineralized bone matrix into muscles of rabbits, rats, mice and guinea pigs [76]. A 
protein, called bone morphogenetic protein (BMP), was found to be involved in the cascade 
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of chemotaxis, mitosis, differentiation and bone formation [77]. Since these pioneering 
reports, the role of BMP in bone formation in vitro and in vivo has been extensively studied. 
A recombinant form of human bone morphogenetic protein type 2 (rhBMP-2) was added to 
bioresorbable PLGA substrates. In those studies, a higher production of bone matrix was 
observed for osteoblasts cultured on substrates covered with rhBMP-2 when compared to 
control [78,79]. A similar experiment was conducted by Hollinger et al. [80], who adsorbed 
rhBMP-2 to a collagen I matrix. When this collagen matrix was implanted into fractured 
bone segments, bone neoformation was observed, as well as integration of the implant into 
the damaged bone. Subsequently, various groups have shown that BMPs are able to induce 
endochondral bone formation when implanted at ectopic sites in experimental animals [81]. 
Although the results are promising, this therapeutic approach might be limited by the size 
of the fracture produced [78]. 
The exact mechanism of osteoinduction by biomaterials is still largely unknown. In addition, 
it is unclear whether the mechanisms of osteoinduction by BMPs and biomaterials are the 
same. In a recent review [81], it was demonstrated marked differences in osteoinduction 
mediated by BMPs and biomaterials: 1) biomaterials always induce intramembraneous bone 
formation, whereas BMP mainly induces endochondral bone formation; 2) in small animals 
such as rodents, bone formation is rarely induced by biomaterials but is easily mediated by 
BMPs; 3) newly formed bone is never observed at the periphery of biomaterials but always 
inside their pores, whereas bone formation induced by BMPs regularly occurs outside the 
carrier and soft tissue is observed distant from the surface of this carrier. 
Gugala et al. [82] investigated the adsorption of proteins and activity of osteoblasts cultured 
for up to 3 weeks on porous and non-porous PDLA membranes. The presence of pores did 
not influence protein adsorption. The authors observed that the cells maintained their 
typical phenotype, formed mineralized nodules, i.e., regions where mineralized organic 
matrix is observed, and produced alkaline phosphatase, an enzyme commonly related to the 
process of biomineralization both in vitro and in vivo. The amount of protein, alkaline 
phosphatase activity and number of cells increased over time and were higher for the 
porous than for the non-porous membranes. In another study, osteoblasts were cultured on 
a gradient of PLLA and PDLLA in order to determine whether the gradient alters the 
pattern of cell interaction with the substrate [83]. Cell adhesion was similar at both ends of 
the gradient, but proliferation was more significant in the smoother PDLLA-rich region than 
in the rougher PLLA-rich region of the gradient. These results demonstrate that, in addition 
to the composition of the substrate, its topography also interferes with the behavior of bone 
cells. Thus, PLLA might not be the ideal substrate for the culture of bone cells. It was 
showed that murine osteoblastic cells more intensely adhered to both dense and porous 
PGA scaffolds than to PLLA scaffolds. Nevertheless, the pattern of cell spreading on the 
substrates was similar after 24 h of culture [84]. 
The use of rapidly degrading synthetic or natural polymer matrices with low mechanical 
properties (high porosity) results in grafts with high biological activity but poor structural 
properties, such as low strength and rigidity. One approach to correct this problem is the 
combination of bioactive ceramics, such as calcium phosphate, with bioresorbable polymers 
in order to improve the mechanical properties of the scaffolds. A composite matrix also 
increases the osteoconductive properties of the scaffolds [73]. Various of these compounds 
are investigated for this purpose. Natural polymers combined with hydroxyapatite-
collagen, hydroxyapatite compounds (chitosan-hydroxyapatite), and PLA copolymers 
(PLA-polyethyleneglycol) have been tested.  
Porous PLLA and PLLA-hydroxyapatite composite scaffolds were seeded with osteoblasts 
and cultured. The cells were found to penetrate deep into the PLLA-hydroxyapatite 
scaffolds and were uniformly distributed. Cell viability and proliferation, as well as the 
expression of bone differentiation markers, were higher for the composite scaffolds when 
compared to pure PLLA [85]. 
Other studies have shown that PCL-calcium phosphate composites confer favorable 
mechanical and biochemical properties (the ceramic confers strength and the polymer 
confers hardness and plasticity). In these scaffolds, the ceramic was homogenously 
distributed in the matrix as being exposed on the surface. The composite was more 
hydrophilic and degradation was accelerated when compared to the pure PCL scaffold [86]. 
In addition, the composite was more receptive to cell adhesion [87]. Another study 
investigating PLA-hydroxyapatite and PCL-hydroxyapatite composites showed that cells 
tended to adhere and spread among hydroxyapatite particles exposed on the surface. The 
presence of hydroxyapatite resulted in a higher activity of bone cells [88]. Despite these 
results, further studies are necessary to identify a material that serves as a substrate for the 
growth of bone cells for tissue regeneration since there is still no ideal compound that 
stimulates bone formation. 
 
8. Bioresorbable devices for skin engineering 
Several groups have investigated different methods for the creation of dermal equivalents 
using various substitutes based on biological materials such as collagen, fibrin, culture of 
epidermal layers, or synthetic materials [89]. However, in patients dermal substitutes have 
shown a slow growth of vascular structures into the dermal components. As a consequence, 
a second surgical procedure is necessary to transplant epidermal components into the 
regenerating wound [90]. 
Much of the knowledge about the mechanisms of skin regeneration by tissue engineering 
stems from three-dimensional scaffold-based fibroblast cultures. The mechanism of action of 
these grafts is based on 1) fibroblast colonization, 2) production of growth factors, 3) a 
substrate for keratinocyte migration, and 4) the wound immune response. Another 
important factor is the migration of keratinocytes to the site of injury. A large number of 
keratinocytes is observed around chronic wounds. However, these cells do not migrate onto 
the wound surface. One of the possible explanations is the degradation of extracellular 
matrix by proteases present at high concentrations in many types of injuries. The control of 
the synthesis and/or degradation of extracellular matrix seem to have marked implications 
in the outcomes of wound healing. Genes encoding extracellular matrix components are 
expressed during wound reconstruction. These compounds include tenascin, decorin and 
some types of collagen (I, III, V and VI). A provisional extracellular matrix is expected to 
provide a good substrate for the migration of cells such as keratinocytes and leukocytes. The 
maintenance of this matrix is therefore important [91]. 
Natural polymers, especially collagen, are extensively studied as a substrate for skin 
regeneration. Collagen has been obtained from different xenogenic sources such as cattle, 
swine and horses. Some types of human collagen are used in the United States with 
approval by the Food and Drug Administration (FDA). Collagen is extremely receptive to 
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of chemotaxis, mitosis, differentiation and bone formation [77]. Since these pioneering 
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tended to adhere and spread among hydroxyapatite particles exposed on the surface. The 
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growth of bone cells for tissue regeneration since there is still no ideal compound that 
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epidermal layers, or synthetic materials [89]. However, in patients dermal substitutes have 
shown a slow growth of vascular structures into the dermal components. As a consequence, 
a second surgical procedure is necessary to transplant epidermal components into the 
regenerating wound [90]. 
Much of the knowledge about the mechanisms of skin regeneration by tissue engineering 
stems from three-dimensional scaffold-based fibroblast cultures. The mechanism of action of 
these grafts is based on 1) fibroblast colonization, 2) production of growth factors, 3) a 
substrate for keratinocyte migration, and 4) the wound immune response. Another 
important factor is the migration of keratinocytes to the site of injury. A large number of 
keratinocytes is observed around chronic wounds. However, these cells do not migrate onto 
the wound surface. One of the possible explanations is the degradation of extracellular 
matrix by proteases present at high concentrations in many types of injuries. The control of 
the synthesis and/or degradation of extracellular matrix seem to have marked implications 
in the outcomes of wound healing. Genes encoding extracellular matrix components are 
expressed during wound reconstruction. These compounds include tenascin, decorin and 
some types of collagen (I, III, V and VI). A provisional extracellular matrix is expected to 
provide a good substrate for the migration of cells such as keratinocytes and leukocytes. The 
maintenance of this matrix is therefore important [91]. 
Natural polymers, especially collagen, are extensively studied as a substrate for skin 
regeneration. Collagen has been obtained from different xenogenic sources such as cattle, 
swine and horses. Some types of human collagen are used in the United States with 
approval by the Food and Drug Administration (FDA). Collagen is extremely receptive to 
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the culture of fibroblasts. We showed that fibroblasts grown on collagen gels produce 
extracellular matrix components such as glycosaminoglycans and fibronectin, forming a 
tissue that resembles reconstituted connective tissue [92]. However, variations in culture 
conditions change the behavior of fibroblasts into that of epithelial cells, with a reduction in 
their migration behavior on the collagen matrix and the production of molecules such as 
collagen IV and laminin [92,93]. Thus, the use of collagen is an interesting model not only 
for the area of tissue reconstruction but also for the study of the differentiation itself of cells 
cultured on it. 
Collagen presents a series of advantages such as availability, biodegradation, bioresorption, 
and resistance to distension. In addition, the properties of collagen can be altered by 
modifying its functional groups. However, there are disadvantages such as rapid 
degradation, high hydrophilicity that may cause significant swelling after implantation, low 
resistance to mechanical compression forces, and high cost of purification, factors limiting 
the use of collagen [94]. The dermal replacement layer of collagen serves as a matrix for the 
growth of macrophages, lymphocytes and endothelial cells derived from the wound. During 
the tissue repair process, an endogenous collagen matrix is deposited, whereas the dermal 
substitute is degraded within approximately 30 days. Furthermore, the skin graft is found to 
be flexible at the site of injury and does not adhere to deeper layers, thus permitting free and 
functional joint movement [95]. 
In view of the positive experiences obtained with collagen, development of an artificial 
dermis was the next target. This type of structure initially consisted of collagen I and 
chondroitin sulfate [96-98]. The so-called artificial dermis is composed of a bilayer 
membrane, in which a matrix of collagen I and chondroitin-6-sulfate is bonded to a layer of 
polysiloxane polymer (silicone). The collagen matrix serves to attract macrophages, 
lymphocytes, fibroblasts and capillaries. In addition to being bioresorbable, the collagen 
matrix is gradually eliminated, permitting the formation of a new dermal matrix. In the 
presence of adequate vascularization, the silicone layer is removed and an epidermal 
autograft is added to the newly formed dermis. The silicone layer represents an additional 
barrier that prevents or minimizes the risk of microbial contamination. The formation of this 
neodermis occurs within 14-21 days. After the completion of regeneration, the neodermis is 
histologically and functionally similar to normal dermis [98,99]. This dermal substitute is 
considered to be an effective treatment for burns and tissue reconstruction in patients with 
cancer [100,101]. 
Since these first results, various research groups have worked to improve the device in an 
attempt to optimize outcomes and to reduce production costs. Among the modifications 
introduced are the removal of chondroitin-6-sulfate and alterations in the storage format of 
the substrate for implantation [102]. Long-term studies have subsequently evaluated the 
efficiency of the implants fabricated, tissue receptivity, degree of regeneration, and strength 
of the skin formed. The data reported were highly satisfactory. The advantages of these 
implants include 1) that the inner layer of the implant spontaneously becomes a structure 
resembling connective tissue, 2) a good long-term postoperative appearance even in the case 
of thin implants, and 3) minimal damage to the donor tissue [43]. 
Intensive research into dermal substitutes and tissue engineering devices has inevitably led 
to bioresorbable polymers. The latter present some advantages over biological substrates: 1) 
since bioresorbable polymers are synthetic, their production can be standardized and 
variations between different production lots are therefore small; 2) these polymers can be 
modified to better fulfill clinical requirements without the loss of their mechanical 
properties; 3) since the possibility of harboring viruses or prions is practically zero, these 
polymers are safer for patients [5,89]. Among the bioresorbable polymers available, the most 
widely used are variations of PLA, such as PLLA, PDLA, PDLLA, PGA, and PLGA. 
Fibroblasts cultured on three-dimensional dense and porous (different pore diameters) 
PLLA membranes were found to adhere to the polymers, to proliferate on them and to 
produce extracellular matrix molecules such as collagen IV and fibronectin [21]. This 
behavior suggests that PLLA can be used as a substrate for skin injuries. However, PLA 
presents low mechanical strength. One alternative would be the formation of copolymers or 
blends to modify the mechanical properties of the material. It was also evaluated the efficacy 
of PLGA membranes with and without plastifier as a dressing for skin injuries. The in vitro 
results showed that the addition of the plastifier reduced the vitreous transition temperature 
(Tg) of the membranes and increased their flexibility. In vivo analysis demonstrated that the 
polymer degraded rapidly when in contact with the skin without causing serious 
inflammation and protected the ulcerated area from the action of external agents. Wound 
healing was faster in the presence of the membranes, a fact indicating their potential use as 
skin dressings [103]. 
Another polymer that is currently gaining interest is poly(hydroxybutyrate-co-
hydroxyvalerate) (PHBV) copolymer, a biodegradable and bioresorbable polymer derived 
from microbial activity. PLLA/PHBV blends are more resistant and, at the same time, more 
malleable than pure PLLA membranes. Since PHBV is more stable, its degradation is slow. 
Thus, the desired strength and degradability are obtained by varying the proportions of 
PLLA and PHBV in the blend. Fibroblasts cultured on different proportions of PLLA/PHBV 
blends (100:0, 60:40, 50:50, 40:60 and 0:100) were found to adhere to the substrates and to 
multiply on them. Again, these cells produced collagen IV and fibronectin on the supports 
[25]. 
New substrates such as poly(ethylene terephthalate)/poly(butylene terephthalate) 
(PEGT/PBT) are also being tested. A fragment of skin equivalent was reconstructed using 
PEGT/PBT scaffolds and cultures of fibroblasts and keratinocytes. The structure formed 
presented various characteristics of differentiated skin, such as an epidermal layer 
expressing several types of keratins on which grew layers of fibroblasts. In addition, 
basement membrane components such as collagen VII, laminin and nidogen were observed 
between these two layers [89]. 
Other alternatives also aimed at dermal regeneration and/or tissue engineering are being 
developed. Some investigators are carefully observing the use of chitosan. Chitosan, or N-
carboxybutylchitosan, is derived from the deacetylation of chitin. Chitosan is a non-
immunogenic compound that presents slow degradation in aqueous medium, even in the 
presence of lysozymes, and its degradation product, glycosamine, is not toxic [104]. 
Chitosan sponges should present, at least in theory, a stable shape and size during the 
period of cell culture. Porous chitosan membranes showed good integrity and favored cell 
spreading [104]. The use of collagen/chitosan blends was proposed taking advantage of the 
characteristics of chitosan and combining them with the properties of collagen. The blends 
were found to present a great water retention capacity, i.e., they were highly hydrophilic, 
and also markedly stimulated the growth of fibroblasts on their surface. Furthermore, the 
addition of chitosan did not reduce the interactivity of cells with collagen. These blends 
support fibroblast infiltration in vivo, a fact facilitating the formation of a neodermis [94]. 
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Since these first results, various research groups have worked to improve the device in an 
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of the skin formed. The data reported were highly satisfactory. The advantages of these 
implants include 1) that the inner layer of the implant spontaneously becomes a structure 
resembling connective tissue, 2) a good long-term postoperative appearance even in the case 
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variations between different production lots are therefore small; 2) these polymers can be 
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spreading [104]. The use of collagen/chitosan blends was proposed taking advantage of the 
characteristics of chitosan and combining them with the properties of collagen. The blends 
were found to present a great water retention capacity, i.e., they were highly hydrophilic, 
and also markedly stimulated the growth of fibroblasts on their surface. Furthermore, the 
addition of chitosan did not reduce the interactivity of cells with collagen. These blends 
support fibroblast infiltration in vivo, a fact facilitating the formation of a neodermis [94]. 
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Finally, our experience and the literature data available indicate that bioresorbable polymers 
are a suitable alternative as long as a growth substrate is chosen whose degradation 
coincides with the regeneration of the dermis-epidermis and that permits 
neovascularization of the skin formed at the site of the implant. Dense or porous PLGA 
membranes may show these characteristics. The search for materials with good properties 
might be a promising alternative for the reconstruction of damaged skin. 
 
9. Conclusion 
The advantages of the use of bioresorbable compounds for tissue engineering are numerous 
when compared to other more traditional surgical procedures. Internal fixation devices used 
in orthopedic surgeries lose their function of maintaining tissues together when structural 
recomposition is completed. The use of bioresorbable implants for internal fixation has the 
advantage of eliminating the second surgical intervention necessary for their removal. In 
addition, the risks of metal implants such as corrosion or friction with bone are avoided. 
Although still under study, the use of bioresorbable polymers is highly promising. New 
compounds are being developed and tested every year and their application perspectives 
are immense. The search for materials that are ideal for each tissue and clinical approach 
continues to represent a challenge. 
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Finally, our experience and the literature data available indicate that bioresorbable polymers 
are a suitable alternative as long as a growth substrate is chosen whose degradation 
coincides with the regeneration of the dermis-epidermis and that permits 
neovascularization of the skin formed at the site of the implant. Dense or porous PLGA 
membranes may show these characteristics. The search for materials with good properties 
might be a promising alternative for the reconstruction of damaged skin. 
 
9. Conclusion 
The advantages of the use of bioresorbable compounds for tissue engineering are numerous 
when compared to other more traditional surgical procedures. Internal fixation devices used 
in orthopedic surgeries lose their function of maintaining tissues together when structural 
recomposition is completed. The use of bioresorbable implants for internal fixation has the 
advantage of eliminating the second surgical intervention necessary for their removal. In 
addition, the risks of metal implants such as corrosion or friction with bone are avoided. 
Although still under study, the use of bioresorbable polymers is highly promising. New 
compounds are being developed and tested every year and their application perspectives 
are immense. The search for materials that are ideal for each tissue and clinical approach 
continues to represent a challenge. 
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